Solithromycin for the treatment of community-acquired bacterial pneumonia-Reference-Cited by-同舟云学术

Solithromycin for the treatment of community-acquired bacterial pneumonia

Published:2016-10-31 Issue:1 Volume:11 Page:5-12
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Viasus Diego¹,Ramos Oscar¹,Ramos Leidy¹,Simonetti Antonella F.²,Carratalà Jordi²³

Affiliation:

1. Faculty of Medicine, Health Sciences Division, Hospital Universidad del Norte and Universidad del Norte, Barranquilla, Colombia

2. Infectious Disease Department, Hospital Universitari de Bellvitge – IDIBELL, Barcelona, Spain

3. Spanish Network for Research in Infectious Diseases (REIPI), and Clinical Science Department, Faculty of Medicine, University of Barcelona, Barcelona, Spain

Funder

Ministerio de Economia y Competitividad, Instituto de Salud Carlos III

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2017.1249852

Reference49 articles.

1. Burden of Community-Acquired Pneumonia in North American Adults

2. Community-Acquired Pneumonia

3. Approaches to estimate the population-based incidence of community acquired pneumonia

4. Prognosis and Outcomes of Patients With Community-Acquired Pneumonia

5. Etiology, Reasons for Hospitalization, Risk Classes, and Outcomes of Community‐Acquired Pneumonia in Patients Hospitalized on the Basis of Conventional Admission Criteria

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics of hospitalized term and preterm infants with community-acquired viral pneumonia;BMC Pediatrics;2022-07-27

2. Current Macrolide Antibiotics and Their Mechanisms of Action;Antibiotic Drug Resistance;2019-08-23

3. Solithromycin monotherapy for treatment of community‐acquired bacterial pneumonia: A meta‐analysis of randomised controlled trials;International Journal of Clinical Practice;2019-03-14

4. Community-Acquired Pneumonia in Children;Recent Patents on Inflammation & Allergy Drug Discovery;2018-09-11

5. Pneumolysin as a potential therapeutic target in severe pneumococcal disease;Journal of Infection;2017-06